Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders
Clinical trial NCT06843044 · RECRUITING
Trial details
- NCT number
- NCT06843044
- Sponsor
- Valenta Pharm JSC
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-13
- Primary completion
- 2027-12-31
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.